Ribociclib - Novartis Oncology
At a glance
- Drug Originator Astex Therapeutics; Mount Sinai Health System
- Drug Licenced by Novartis Oncology
- Drug Class Amides; Aminopyridines; Antineoplastics; Piperazines; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 9
- NDAs 1
- International Patents 187
- Patent Applications 921
Table of Contents
Disclaimer